POSB152 The Health and Budget Impact of Safer Lower Dose Direct Oral Anticoagulant Formulations in Non-Valvular Atrial Fibrillation Patients

Autor: Fens, T, van Puijenbroek, EP, Boersma, C, Postma, M
Zdroj: In Value in Health January 2022 25(1) Supplement:S90-S90
Databáze: ScienceDirect